August 20, 2003
Abbott Labs Has Recalled BUPIVACAINE
HCL and EPINEPHRINE
The Food and Drug Administration (FDA) released the following information.
0.25% BUPIVACAINE HCL and EPINEPHRINE 1:200,000 Injection, 30 mL Single-dose
Vials, Sterile, nonpyrogenic, Rx only. Recall # D-303-3.
Lot number 03-504-DK.
Abbott Labs., North Chicago, IL, by letter on July 15, 2003. Firm initiated
recall is ongoing.
Mislabeled; expiration date is incorrectly printed on vial label as "1
October 200" rather than correctly as "1 October 2004".
VOLUME OF PRODUCT IN COMMERCE